The First Biosimilar reached the US market… and it’s from Novartis
Biosimilar or copies of biological drugs are arriving on the market. After Europe, US gets…
As one of the leading causes of death worldwide, cancer receives great focus from the life sciences industry. Indeed, it’s the largest therapeutic focus area for biotech and pharma companies, which are working on a large number of therapeutic approaches, including small molecules, T cell therapies, and antibody therapies.
Global cancer drug sales are estimated to reach €221B by 2024. The top 10 blockbuster drugs are sold by big pharma companies, like Roche, Merck, AbbVie, and Bristol-Myers Squibb. Examples of blockbusters include Keytruda, Rituxan, and Herceptin.
Biotech companies are doing a fair bit of the work as well. Read on to keep up to date with the latest oncology research, discoveries, and market developments.
A Guide to Current Therapies in Immuno-Oncology
From a rich history to a growing number of therapies, the immuno-oncology landscape has changed rapidly over the last decade. In this report, we look into its past, discuss present therapeutic approaches, and provide an outlook into its future.
Go to ReportBiosimilar or copies of biological drugs are arriving on the market. After Europe, US gets…
Side effects of cancer treatments are almost as feared as the disease itself. But what…
MD Anderson is expanding its Immatics sharehold to spawn new Houston-based subsidiary Immatics US through…
A pioneering CAR-T cell therapy study from Novartis and the University of Pennsylvania demonstrates the…
Adaptimmune has had exciting results regarding the ongoing battle with Synovial Sarcoma. GSK looks to…
Immuno-oncology is a Biotech field that is more than just hype - it could solve…
Sofinnova Ventures and Novo A/S step into one of the biggest European series C financing…
The Eurostars program supports the Dutch start-up Oncodrone with fresh money to bring its metastasis-blocking…
Two German biotechs with highly successful platforms join forces to fight cancer. MorphoSys and Immatics…
The European Commission granted marketing authorisation for United Therapeutics' Unituxin for the treatment of neuroblastoma in…
Cancer occurs in uncountable forms, and we are far away from understanding all the mechanisms…
Roche just dropped a first-generation antibody-based treatment preventing cancer cells from proliferating. Interestingly enough, the…